Trichorzin PAu 4
| Internal ID | 1ca8c47f-847d-4078-b727-fa65970d8e26 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[[2-[[2-[[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[2-[[2-[(2-acetamido-2-methylpropanoyl)amino]-3-hydroxypropanoyl]amino]propanoylamino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-2-methylpropanoyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-N-[1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]pentanediamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C83H138N20O23/c1-42(2)36-52(64(115)99-83(23,24)75(126)103-35-25-26-55(103)66(117)90-53(37-43(3)4)65(116)98-82(21,22)74(125)102-79(15,16)70(121)91-50(31-33-56(84)108)61(112)88-48(40-104)38-47-27-29-49(107)30-28-47)89-58(110)39-86-68(119)76(9,10)100-67(118)59(44(5)6)94-72(123)78(13,14)97-63(114)51(32-34-57(85)109)92-71(122)80(17,18)101-73(124)81(19,20)96-60(111)45(7)87-62(113)54(41-105)93-69(120)77(11,12)95-46(8)106/h27-30,42-45,48,50-55,59,104-105,107H,25-26,31-41H2,1-24H3,(H2,84,108)(H2,85,109)(H,86,119)(H,87,113)(H,88,112)(H,89,110)(H,90,117)(H,91,121)(H,92,122)(H,93,120)(H,94,123)(H,95,106)(H,96,111)(H,97,114)(H,98,116)(H,99,115)(H,100,118)(H,101,124)(H,102,125) |
| InChI Key | MMHGWPWSPHZCQC-UHFFFAOYSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C83H138N20O23 |
| Molecular Weight | 1784.10 g/mol |
| Exact Mass | 1783.02437073 g/mol |
| Topological Polar Surface Area (TPSA) | 662.00 Ų |
| XlogP | -2.10 |
| Atomic LogP (AlogP) | -4.62 |
| H-Bond Acceptor | 23 |
| H-Bond Donor | 22 |
| Rotatable Bonds | 49 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8020 | 80.20% |
| Caco-2 | - | 0.8595 | 85.95% |
| Blood Brain Barrier | - | 0.8500 | 85.00% |
| Human oral bioavailability | - | 0.7000 | 70.00% |
| Subcellular localzation | Mitochondria | 0.5068 | 50.68% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8361 | 83.61% |
| OATP1B3 inhibitior | + | 0.9334 | 93.34% |
| MATE1 inhibitior | - | 0.9400 | 94.00% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9548 | 95.48% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8757 | 87.57% |
| CYP3A4 substrate | + | 0.7442 | 74.42% |
| CYP2C9 substrate | - | 0.7904 | 79.04% |
| CYP2D6 substrate | - | 0.8206 | 82.06% |
| CYP3A4 inhibition | - | 0.8285 | 82.85% |
| CYP2C9 inhibition | - | 0.9035 | 90.35% |
| CYP2C19 inhibition | - | 0.8411 | 84.11% |
| CYP2D6 inhibition | - | 0.8602 | 86.02% |
| CYP1A2 inhibition | - | 0.9390 | 93.90% |
| CYP2C8 inhibition | + | 0.7407 | 74.07% |
| CYP inhibitory promiscuity | - | 0.9503 | 95.03% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.6238 | 62.38% |
| Eye corrosion | - | 0.9889 | 98.89% |
| Eye irritation | - | 0.8954 | 89.54% |
| Skin irritation | - | 0.7759 | 77.59% |
| Skin corrosion | - | 0.9159 | 91.59% |
| Ames mutagenesis | - | 0.7278 | 72.78% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7220 | 72.20% |
| Micronuclear | + | 0.7700 | 77.00% |
| Hepatotoxicity | + | 0.5282 | 52.82% |
| skin sensitisation | - | 0.8749 | 87.49% |
| Respiratory toxicity | + | 0.8111 | 81.11% |
| Reproductive toxicity | + | 0.9556 | 95.56% |
| Mitochondrial toxicity | + | 0.9250 | 92.50% |
| Nephrotoxicity | - | 0.7584 | 75.84% |
| Acute Oral Toxicity (c) | III | 0.6229 | 62.29% |
| Estrogen receptor binding | - | 0.6030 | 60.30% |
| Androgen receptor binding | + | 0.7508 | 75.08% |
| Thyroid receptor binding | + | 0.7744 | 77.44% |
| Glucocorticoid receptor binding | + | 0.8348 | 83.48% |
| Aromatase binding | + | 0.8138 | 81.38% |
| PPAR gamma | + | 0.7865 | 78.65% |
| Honey bee toxicity | - | 0.7405 | 74.05% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | + | 0.5024 | 50.24% |
| Fish aquatic toxicity | - | 0.4176 | 41.76% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.97% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.79% | 96.61% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.59% | 96.09% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 97.58% | 94.45% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.21% | 91.11% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 97.13% | 83.14% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 97.07% | 93.10% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 97.04% | 97.23% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 96.37% | 100.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 96.17% | 93.56% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 95.97% | 91.19% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.83% | 97.09% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 95.53% | 95.17% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 95.36% | 98.94% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 95.35% | 98.33% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 94.72% | 95.38% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 94.54% | 100.00% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 94.42% | 83.10% |
| CHEMBL236 | P41143 | Delta opioid receptor | 93.68% | 99.35% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 93.49% | 94.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 93.45% | 97.14% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 93.44% | 99.17% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 92.90% | 97.21% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.38% | 99.17% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 92.14% | 96.03% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 92.12% | 95.89% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 90.85% | 93.33% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 89.96% | 93.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 89.89% | 90.71% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 89.78% | 98.89% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 89.57% | 96.67% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 89.54% | 100.00% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 89.26% | 94.45% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 89.09% | 100.00% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 88.88% | 82.69% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 88.59% | 97.43% |
| CHEMBL2535 | P11166 | Glucose transporter | 88.39% | 98.75% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 88.25% | 95.89% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 87.97% | 82.86% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 87.96% | 92.80% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 87.78% | 89.33% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 87.65% | 96.28% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 87.39% | 96.95% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 87.31% | 96.67% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 86.84% | 98.24% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 85.77% | 96.90% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 85.43% | 89.63% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 85.20% | 97.64% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 84.70% | 96.00% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 84.30% | 98.05% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 83.51% | 96.67% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 83.44% | 82.38% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 83.20% | 95.83% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 82.93% | 90.93% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 81.99% | 85.00% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 81.87% | 89.00% |
| CHEMBL2163183 | Q9NXA8 | NAD-dependent protein deacylase sirtuin-5, mitochondrial | 81.83% | 96.53% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 81.49% | 97.50% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 81.41% | 86.67% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 80.84% | 96.47% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 80.63% | 95.56% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 80.20% | 90.08% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139585378 |
| LOTUS | LTS0254301 |
| wikiData | Q77421170 |